FACULTAD DE FARMACIA
Facultad
Hospital Universitario Príncipe de Asturias
Alcalá de Henares, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Príncipe de Asturias (10)
2020
-
Factors associated with the number of drugs in darunavir/cobicistat regimens
Journal of Antimicrobial Chemotherapy, Vol. 75, Núm. 1, pp. 208-214
2019
-
Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR
Scientific Reports, Vol. 9, Núm. 1
2018
-
Home and ambulatory artificial nutrition (NADYA) report. home parenteral nutrition in Spain, 2017
Nutricion Hospitalaria, Vol. 35, Núm. 6, pp. 1491-1496
2017
-
Nutrición parenteral domiciliaria en españa 2016; informe del grupo de nutrición artificial domiciliaria y ambulatoria nadya
Nutricion Hospitalaria, Vol. 34, Núm. 6, pp. 1497-1501
2015
-
Comparison of the prognostic value of liver biopsy and FIB-4 index in patients coinfected with HIV and hepatitis C virus
Clinical Infectious Diseases, Vol. 60, Núm. 6, pp. 950-958
-
Dual treatment with lopinavir-ritonavir plus lamivudine versus triple treatment with lopinavir-ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): A randomised, open-label, non-inferiority trial
The Lancet Infectious Diseases, Vol. 15, Núm. 7, pp. 785-792
2014
-
Effects of sustained viral response in patients with HIV and chronic hepatitis C and nonadvanced liver fibrosis
Journal of Acquired Immune Deficiency Syndromes, Vol. 66, Núm. 3, pp. 280-287
-
Nutrición Parenteral Domiciliaria en España 2011 y 2012; informe del grupo de nutrición artificial domiciliaria y ambulatoria NADYA
Nutricion Hospitalaria, Vol. 29, Núm. 6, pp. 1360-1365
-
Nutrición enteral domiciliaria en Espana; registro NADYA del ano 2011-12
Nutricion Hospitalaria, Vol. 29, Núm. 6, pp. 1339-1344
2011
-
Effect of accompanying antiretroviral drugs on virological response to pegylated interferon and ribavirin in patients co-infected with HIV and hepatitis C virus
Journal of Antimicrobial Chemotherapy, Vol. 66, Núm. 12, pp. 2843-2849